Global Point of Care Molecular Diagnostics Market, 2023 by Product & Service, Application, Technology, End User

DUBLIN, May 29, 2018 /PRNewswire/ --

The "Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology, End User (Physician Office, ICUS) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global point of care (POC) molecular diagnostics market is projected to reach USD 1440.2 Million in 2023 from USD 725.5 Million in 2018, at CAGR of 14.7%.

POC molecular diagnostics are point-of-care setting devices used by healthcare professionals to detect and diagnose various diseases in humans.

In this report, the POC molecular diagnostics market has been categorized by product & service, applications, technology, end user, and region.

The market is broadly segmented into instruments, assays & kits, and services & software based on the basis of products & services. The assays & kits segment is expected to account for the largest share of the global POC molecular diagnostics market. This segment is also projected to register the highest CAGR during the forecast period.

Based on the applications, the market is segmented into respiratory diseases, hospital-acquired infections (HAIs), sexually transmitted diseases (STDs), oncology, hepatitis, and other applications (meningococcal meningitis, malaria, Herpes Simplex Virus, Ebola, Zika virus).

The respiratory diseases application segment is expected to account for the largest share of the global POC molecular diagnostics market in 2018. The large share of this segment can be attributed to the rising prevalence of influenza and TB, technological advancements in diagnostic tests, and the growing preference towards POC molecular diagnostics.

By technology, the POC molecular diagnostics market is segmented into RT-PCR, INAAT, and others technologies. In 2018, the RT-PCR segment is expected to account for the largest share of the global POC molecular diagnostics market. The large share of this segment can be attributed to the growing use of RT-PCR in proteomics and genomics and access to portable, easy-to-use devices.

In 2018, North America is expected to account for the largest share of the global POC molecular diagnostics market followed by Europe. The growing prevalence of infectious diseases, increasing number of CLIA product approvals, and rising government initiatives are the major factors driving the growth of this market in North America.

However, Asia Pacific is expected to grow at highest CAGR during the forecast period. Growing initiatives by market players, rising demand for influenza A/B tests, and increasing patient population base in this region are the key factors driving this market.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 POC Molecular Diagnostics Market Overview
4.2 Geographic Analysis: APAC POC Molecular Diagnostics Market, By Technology and Product
4.3 POC Molecular Diagnostics Market, By Application
4.4 POC Molecular Diagnostics Market, By End User

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Worldwide Prevalence of Infectious Diseases
5.2.1.2 Rising Focus on Decentralized Diagnostics
5.2.1.3 Growing Demand for Clia-Waived Molecular POC Tests
5.2.2 Restraints
5.2.2.1 Inadequate Reimbursements
5.2.2.2 Stringent and Time-Consuming Regulatory Policies Significantly Increase the Product Launch Cycle
5.2.3 Opportunities
5.2.3.1 Growing R&D Activities in Molecular Diagnostic Testing
5.2.3.2 Increasing Penetration of POC Molecular Diagnostic Tests in China, India, and Brazil

6 Point-of-Care (POC) Molecular Diagnostics Market, By Application
6.1 Introduction
6.1.1 Respiratory Diseases
6.1.2 Sexually Transmitted Diseases
6.1.3 Hospital-Acquired Infections
6.1.4 Oncology
6.1.5 Hepatitis
6.1.6 Other Applications

7 Point-of-Care Molecular Diagnostics Market, By Technology
7.1 Introduction
7.2 RT -PCR
7.3 INAAT
7.4 Other Technologies

8 Point-of-Care (POC) Molecular Diagnostics Market, By Product & Service
8.1 Introduction
8.2 Assays & Kits
8.3 Instruments/Analyzers
8.4 Software & Services

9 Point-of-Care Molecular Diagnostics Market, By End User
9.1 Introduction
9.2 Physician Offices
9.3 Hospital Emergency Departments & Intensive Care Units
9.4 Research Institutes
9.5 Other End Users

10 Point-of-Care Molecular Diagnostics Market, By Region
10.1 Introduction
10.2 North America
10.3 Europe
10.4 Asia Pacific
10.5 RoW

11 Competitive Landscape
11.1 Market Overview
11.2 Market Ranking Analysis, 2017
11.3 Competitive Situation and Trends
11.3.1 Product Launches and Approvals
11.3.2 Acquisitions
11.3.3 Collaborations/Agreements/Partnerships
11.3.4 Expansions

12 Company Profile
12.1 Abbott Laboratories
12.2 Danaher Corporation
12.3 Biomrieux Sa
12.4 Roche Diagnostics
12.5 Quidel
12.6 Meridian Bioscience
12.7 Mesa Biotech
12.8 Genepoc
12.9 DxNA
12.10 Atlas Genetics
12.11 Spartan Bioscience
12.12 Biocartis

For more information about this report visit https://www.researchandmarkets.com/research/g5vb6g/global_point_of?w=5

Media Contact:

Laura Wood, Senior Manager

[email protected]

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets